ArticleClinical and translational medicine2021
Sofosbuvir improves HCV-induced insulin resistance by blocking IRS1 degradation.
Esther Rey et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
2021
this papercites it